Biocon: Company Strengthens Diabetes Care Efforts In Malaysia As Partner Duopharma Biotech Wins Insulin Tenders Exceeding MYR 225 Million, Providing Short-Acting Recombinant Human Insulin, Insulin Glargine, And Insulin Aspart.
Biocon: Company Strengthens Diabetes Care Efforts In Malaysia As Partner Duopharma Biotech Wins Insulin Tenders Exceeding MYR 225 Million, Providing Short-Acting Recombinant Human Insulin, Insulin Glargine, And Insulin Aspart.